Healthcare -
Biotechnology - NASDAQ - US
$ 44.405
-3.47 %
$ 5.26 B
Market Cap
-8.44
P/E
CYTK - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities CYTK - Cytokinetics, Incorporated
239 M
LAST VALUE
90.24%
2 YEAR CAGR
115.62%
5 YEAR CAGR
66.06%
10 YEAR CAGR